Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma
Background: The possible involvement of p53 signaling, FGFR3 expression, and <i>FGFR3</i> mutation rates in the prediction of the NMIBC anti-PD-L1 treatment response needs to be clarified. The main aim of our study was to explore predictive value of p53 expression, FGFR3 expression, and...
Main Authors: | Ekaterina Blinova, Elena Samishina, Olga Deryabina, Dmitry Blinov, Dmitry Roshchin, Evgeniia Shich, Oxana Tumutolova, Ilya Fedoseykin, Anna Epishkina, Haydar Barakat, Andrey Kaprin, Kirill Zhandarov, Dmitrij Perepechin, Dmitrij Merinov, Gordey Brykin, Karen Arutiunian, Stanislav Serebrianyi, Artem Mirontsev, Andrew Kozdoba |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/18/9856 |
Similar Items
-
FGFR1–4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer
by: Joanna Moes-Sosnowska, et al.
Published: (2022-09-01) -
Biological Significance and Targeting of the FGFR Axis in Cancer
by: Athina-Myrto Chioni, et al.
Published: (2021-11-01) -
Emerging Roles of Fibroblast Growth Factor 10 in Cancer
by: Natasha S. Clayton, et al.
Published: (2018-10-01) -
Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer
by: Delfina Popiel, et al.
Published: (2024-01-01) -
Differential expression of FGFRs signaling pathway components in bladder cancer: A step toward personalized medicine
by: Ousati Ashtiani Z, et al.
Published: (2017-12-01)